Navigation Links
Solos Endoscopy, Inc. Announces Recapitalization Plan for 2011
Date:11/19/2010

BOSTON, Nov. 19, 2010 /PRNewswire-FirstCall/ -- Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce that the Company's management has approved its 2011 recapitalization plan in order to position itself for growth over the next twelve months. The recapitalization plan is designed to increase financial flexibility for Solos and its shareholders.

The recapitalization plan allows Solos greater flexibility to utilize the assets of the Company in the future for corporate purposes; including raising capital, acquisitions or employee compensation, with limited dilution of existing stockholder voting rights.

"We are very pleased that the recapitalization allows us to pursue our existing strategy more aggressively," stated Bob Segersten, President of Solos Endoscopy, Inc.

Throughout the remainder of 2010, the Company will continue its new product development for the MammoView® product line. In addition, Solos plans to achieve market expansion through its efforts to meet the requirements of the ISO 13485 standard and ultimately obtain the CE Mark and the permission to sell medical devices in the European Union and Canada.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a HealthCare instrument company whose mission is to develop and market high quality and innovative instruments for the screening, diagnosis, treatment and management of medical conditions. Additional information on its FDA approved products is available on the Company's website at: www.solosendoscopy.com.

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.


'/>"/>
SOURCE Solos Endoscopy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Solos Endoscopy, Inc. Revenue Grows 34.8% for Third Quarter 2010
2. Solos Endoscopy, Inc. Announces Results of 2010 Annual Shareholder Meeting
3. Solos Endoscopy, Inc. to Hold Annual Shareholder Meeting September 28, 2010
4. Solos Endoscopy, Inc. Develops Relay Lense Adapter System For MammoView® Product Line
5. Solos Endoscopy, Inc. Increases Revenues by 10 Percent for First Quarter 2010 as Compared to First Quarter 2009
6. Solos Endoscopy, Inc. Appoints Experienced CFO To Financial Leadership Amidst Growth
7. Solos Endoscopy, Inc. Granted U.S. Trademark for MammoView(R)
8. Solos Endoscopy, Inc. Set To Develop European Union Conforming CE Mark Technical File
9. Solos Endoscopy, Inc. Set To Develop New Polymer Dilator For MammoView(TM) System
10. Solos Endoscopy, Inc. Retains Expert Resource to Meet Requirements for ISO 13485 Quality Management System Initiative
11. Solos Endoscopy, Inc.s Breast Endoscopy System Featured in February Issue of General Surgery News
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... , April 20, 2017   ZappRx, Inc ., ... specialty drug prescribing process, today announced it closed $25 million ... a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included participation ... round in 2014, and GV (formerly Google Ventures). ...
(Date:4/20/2017)... , April 20, 2017 Eyevensys, ... the first non-viral gene expression technology that enables the ... eye to address a wide range of ophthalmic diseases, ... and Healthcare products Regulatory Agency (MHRA) to advance its ... ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... April 28, 2017 , ... Datta Endoscopic ... has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a Board ... Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic is ...
(Date:4/28/2017)... ... April 28, 2017 , ... From April 30 to May ... Medicine will host industry leaders for the annual spring Convention & Expo, called ... industry adapt to the issues currently affecting urgent care and on-demand healthcare. , ...
(Date:4/28/2017)... Diego, Ca (PRWEB) , ... April 28, 2017 , ... ... property management industry in the coastal communities. After Tina Howe joined the team, the ... and happy employees, honest services at affordable rates, and giving back to the San ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is pleased ... has 20+ years of experience within the beauty industry, ranging from marketing, retail ... of high-end cosmetic brands, retail brands and outlets in Canada and New York. ...
(Date:4/28/2017)... ... 28, 2017 , ... NuevaCare, a leading home care agency based in San ... Alto, is proud to announce information upgrades to its blog in the form of ... on topics such as home care (generally) as well as senior care and home ...
Breaking Medicine News(10 mins):